|
New Frontiers in Biotechnology and the Role of the ATP
|
Proteomics | |||||||||||
| Wednesday, November 17, 1999 | |
| 12:30 p.m. | N. Leigh Anderson, Ph D., President of Large Scale Biology Corporation
Proteomics Technology in the Post-Genome Era |
| 1:15 p.m. | Tom Ransohoff, Ph.D., VP, Dyax Applications of Phage Display in Proteomics |
| 2:00 p.m. | Karl Clauser, Ph.D., Scientist, Millennium Pharmaceuticals Inc. Tracking Differential Protein Expression in Plasma of Knockout Mice Using LC/MS/MS |
| 2:45 p.m. | William E. Rich, Ph.D., President & CEO, Ciphergen Biosystems, Inc. Recent Advances in ProteinChip™ Proteomics Investigations |
 |
 |
ATP website comments: webmaster-atp@nist.gov
• Technical ATP inquiries: InfoCoord.ATP@nist.gov Privacy policy / security notice / accessibility statement • NIST Disclaimer • NIST Information Quality Standards NIST is an agency of the U.S. Commerce Department's Technology Administration. |
Return to 